HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Florida Hand Sanitizer Firm’s Pandemic Experience: Recall Contaminated Product, Cease Production

Executive Summary

Sanit Technologies must provide FDA with full reconciliation for all hand sanitizers not recalled and detailed plan of business closing. Warning letter notes its product’s risk to vulnerable populations and its distribution to schools with young children.

You may also be interested in...



Ulta Ups FY 2022 Sales Projections; US House Targeting PFAS Research; Personal Care News In Brief

Ulta Beauty doubles its comparable sales growth projections for fiscal 2022 to between 6% and 8%, citing faster-than-expected makeup recovery. German company Henkel is recalling Alterna Bond Repair Leave-in Heat Protection Spray due to potential microbial contamination. More news in brief.

The Quality Lowdown: Enforcement And Compliance During A Lingering Pandemic

US FDA oversees plants straining to meet demand for COVID-19 vaccines and treatments, while cracking down on adulterated hand sanitizers.

US OTC Monograph Facilty Fees Increase With Pandemic-Inspired Sanitizer Makers Exempted

FDA publishes second notice on FY2021 rates for OTC monograph drug user fee program. With fewer firms paying, those still subject to facility fees will pay more so the total collected matches amount Congress authorized agency to collect, nearly $23.3m.

Related Content

Topics

Latest News
See All
UsernamePublicRestriction

Register

RS151644

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel